https://pipelinereview.com/Sarepta-Therapeutics-Announces-Initiation-of-EMBARK-a-Global-Pivotal-Study-of-SRP-9001-a-Gene-Therapy-for-the-Treatment-of-Duchenne-Muscular-Dystrophy/